A Study of VCT220 Tablets in Adults With Type 2 Diabetes and Inadequate Blood Glucose Control
A phase 2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 120 participants.
Also called NCT07872436
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 120 participants
- Sponsor
- Vincentage Pharma Co., Ltd
- Registry
-
NCT07872436
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07872436. Randomized; triple masking; primary purpose treatment. Start 2026-11-01 (anticipated); primary completion 2027-07-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of VCT220 Tablets in Adults With Type 2 Diabetes and Inadequate Blood Glucose Control
- Acronym
- VICTOR-DM
- Condition
- Type 2 Diabetes Mellitus (DM)
- Intervention (Drug)
- VCT220 tablets
- Intervention (Drug)
- Placebo
- Lead sponsor
- Vincentage Pharma Co., Ltd
Record details
- Record id
cardio:ct-nct07872436- Content hash
d8ea4da2d81d0409cc1feb545557b47a18c1cd0d7a993ba3ade5c89f8b81a5a1